99 related articles for article (PubMed ID: 3712763)
1. Pharmacokinetics and disposition of (2''R)-4'-O-tetrahydropyranyladriamycin in dogs.
Iguchi H; Tone H; Kiyosaki T; Ishikura T; Takeuchi T; Umezawa H
Jpn J Antibiot; 1986 Feb; 39(2):638-52. PubMed ID: 3712763
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics and disposition of a new anticancer antibiotic (2''R)-4'-O-tetrahydropyranyladriamycin in rats. Distribution and excretion after a single administration].
Tone H; Iguchi H; Fujigaki M; Nishio M; Esumi Y; Takaichi M; Tsutsumi S; Yokoshima T
Jpn J Antibiot; 1986 Feb; 39(2):612-28. PubMed ID: 3712761
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics and disposition of a new antitumor antibiotic (2''R)-4'-O-tetrahydropyranyladriamycin in rats. Distribution and excretion after multiple administration].
Tone H; Iguchi H; Shomura T; Komiya I; Nishio M
Jpn J Antibiot; 1986 Feb; 39(2):629-37. PubMed ID: 3712762
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and disposition of 4'-O-tetrahydropyranyladriamycin in mice by HPLC analysis.
Iguchi H; Tone H; Ishikura T; Takeuchi T; Umezawa H
Cancer Chemother Pharmacol; 1985; 15(2):132-40. PubMed ID: 4017162
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of 4'-O-tetrahydropyranyladriamycin given on a weekly schedule in patients with advanced breast cancer.
Mader RM; Zilg H; Schlappack O; Steger GG; Baur M; Greifenberg B; Heberle U; Dittrich C
Cancer Chemother Pharmacol; 1995; 37(1-2):91-6. PubMed ID: 7497603
[TBL] [Abstract][Full Text] [Related]
6. [Comparative studies on the pharmacokinetics between THP and adriamycin in the same patients].
Nakajima O; Imamura Y; Matsumoto A; Koyama Y; Shomura T; Kawamura K; Murata S
Gan To Kagaku Ryoho; 1986 Feb; 13(2):261-70. PubMed ID: 3947106
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of doxorubicin, (2"R)-4'-O-tetrahydropyranyl-adriamycin and aclarubicin.
Fujita H; Ogawa K; Tone H; Iguchi H; Shomura T; Murata S
Jpn J Antibiot; 1986 May; 39(5):1321-36. PubMed ID: 3463778
[TBL] [Abstract][Full Text] [Related]
8. [Effect of (2"R)-4'-O-tetrahydropyranyladriamycin, a new antitumor antibiotic, on the cardiac function of hamsters].
Tone H; Hirano S; Shirai M; Kumagai H; Okajima Y; Wakabayashi T
Jpn J Antibiot; 1986 Feb; 39(2):547-68. PubMed ID: 3712757
[TBL] [Abstract][Full Text] [Related]
9. A high performance liquid chromatographic method of analysis of 4'-O-tetrahydropyranyladriamycin and their metabolites in biological samples.
Matsushita Y; Iguchi H; Kiyosaki T; Tone H; Ishikura T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1983 Jul; 36(7):880-6. PubMed ID: 6885639
[TBL] [Abstract][Full Text] [Related]
10. Contradistinction between doxorubicin and epirubicin: in-vivo metabolism, pharmacokinetics and toxicodynamics after single- and multiple-dosing in rats.
Ramanathan-Girish S; Boroujerdi M
J Pharm Pharmacol; 2001 Jul; 53(7):987-97. PubMed ID: 11480551
[TBL] [Abstract][Full Text] [Related]
11. [Toxicological studies on (2''R)-4'-O-tetrahydropyranyladriamycin, a new antitumor antibiotic. Its acute toxicity in beagle dogs].
Kurebe M; Yokota M; Watanabe H; Kawaoto H; Suzuki H; Seki M; Hayasaka H; Nakamura N
Jpn J Antibiot; 1986 Jan; 39(1):265-302. PubMed ID: 3702061
[TBL] [Abstract][Full Text] [Related]
12. Acute local irritative effect of (2''R)-4'-O-tetrahydropyranyladriamycin, a new antitumor antibiotic.
Tone H; Kiyosaki T; Cuthbert JA; Carr SM; Aitken R
Jpn J Antibiot; 1986 Feb; 39(2):569-81. PubMed ID: 3712758
[TBL] [Abstract][Full Text] [Related]
13. [Tissue levels of pirarubicin (THP) in dogs following intra-arterial infusion].
Sumiyoshi Y; Yokota K; Akiyama M; Kawaoto H; Kosugi I
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1621-6. PubMed ID: 1872619
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacology and toxicity of 4'-O-tetrahydropyranyladriamycin.
Miller AA; Schmidt CG
Cancer Res; 1987 Mar; 47(5):1461-5. PubMed ID: 3815348
[TBL] [Abstract][Full Text] [Related]
15. [Intravesical chemotherapy of (2''R)-4'-O-tetrahydropyranyladriamycin in bladder tumor].
Masuda H; Hirose J; Suzuki K; Tajima A; Aso Y
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2411-4. PubMed ID: 3729494
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of (2''R)-4'-O-tetrahydropyranyl adriamycin on human gastric cancer cell lines in vitro and in vivo.
Saikawa Y; Kubota T; Kuo TH; Furukawa T; Kase S; Tanino H; Ishibiki K; Kitajima M; Hoffman RM
Anticancer Res; 1994; 14(2A):469-73. PubMed ID: 8017850
[TBL] [Abstract][Full Text] [Related]
17. [Phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with solid tumors. Multi-Institutional Cooperative Study].
Saito T; Kasai Y; Wakui A; Furue H; Majima H; Nitani H; Niijima T; Takeda C; Abe O; Koyama Y
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1060-9. PubMed ID: 3963850
[TBL] [Abstract][Full Text] [Related]
18. [Toxicological studies on (2''R)-4'-O-tetrahydropyranyladriamycin, a new antitumor antibiotic. Acute toxicity study in mice].
Tone H; Shirai M; Onoue F; Kumagai H
Jpn J Antibiot; 1986 Jan; 39(1):250-8. PubMed ID: 3702059
[TBL] [Abstract][Full Text] [Related]
19. [Tissue concentration of intravesically instilled (2"R)-4'-o-tetrahydropyranyl-adriamycin or adriamycin in superficial bladder cancer].
Saika T; Tsushima T; Nasu Y; Noda M; Akebi N; Kaku S; Takamatsu M; Ohmori H; Uno S; Johsen T
Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1206-10. PubMed ID: 8355436
[TBL] [Abstract][Full Text] [Related]
20. [Tissue concentration of 4'-O-tetrahydropyranyladriamycin in renal cell carcinoma and urinary bladder tumor].
Masuda H; Hirose J; Ohtawara Y; Suzuki K; Tajima A; Aso Y; Shomura T; Kawamura K
Gan To Kagaku Ryoho; 1985 Oct; 12(10):1975-9. PubMed ID: 4051513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
